FDA Import Refusal 799-9585529-3/11/1 — ASCENDIS PHARMACEUTICAL COMPANY
The FDA refused shipment 799-9585529-3/11/1 from ASCENDIS PHARMACEUTICAL COMPANY (South Africa) on Mar 19, 2024. The refused product falls under Drugs and Biologics — LAMIVUDINE (ANTI-VIRAL). Cited charges: 118,75
Refusal details
- Date
- Mar 19, 2024
- Country
- South Africa
- Product Category
- Drugs and Biologics
- Product Code
- 62VDA32 LAMIVUDINE (ANTI-VIRAL)
- Charges
- 118,75